Navigation Links
Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
Date:6/1/2009

EMERYVILLE, Calif., June 1 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (Nasdaq: NTII) (NTI(R)) today announced that Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) has announced the results from its Phase 3 Clinical Program for XERECEPT(R) in patients with edema associated with brain tumors and from preclinical studies of XERECEPT in brain tumor models.

NTI sold the worldwide rights and assets related to XERECEPT to Celtic Pharma in November 2005. If Celtic Pharma commercializes XERECEPT, NTI is entitled to receive milestone payments upon the achievement of certain regulatory approvals and NTI is also entitled to receive profit-sharing payments on sales in the United States and royalties on sales elsewhere in the world. If Celtic Pharma sells or licenses the commercialization rights to XERECEPT, NTI is entitled to a percentage of the net proceeds received by Celtic.

NTI has not reviewed the data from the clinical trials or the preclinical studies and cannot independently corroborate the results reported by Celtic Pharma.

The text of Celtic Pharma's press release is as follows:

Celtic Pharma Announces Results of a Phase III Program Evaluating XERECEPT(R) in Patients with Primary and Metastatic Brain Tumors

Administration of XERECEPT(R) in Patients with Cerebral Edema Demonstrated Clinically Significant Reductions in Steroid Usage Compared to Placebo

New Preclinical Studies Indicate XERECEPT(R) May Have Direct Anti-Tumor and Angiogenesis Inhibition Activity

New York, London and Bermuda, June 1, 2009 - Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today reported at the American Society of Clinical Oncology meeting in Orlando the results of two randomized double-blind, placebo-controlled Phase
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
2. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
3. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
4. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
5. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
8. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
9. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
10. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
11. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
(Date:8/29/2014)... 2014 Research and Markets has ... Industry Report, 2014-2017" report to their offering. ... proportion of reimbursement for medical expenses, the Chinese orthopedic ... scale presenting a CAGR of 19.2% during 2009-2013. Trauma ... segments of orthopedic instruments in China ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and Markets ... Drug Pipeline Insight 2014" report to their offering. ... US is one of the largest segments of pharmaceuticals industry. ... rate, while the available therapies were unable to meet the ... the market for CNS disorder, especially over the past two ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2US CNS Disorders Drug Pipeline Insight 2014 2
... Mass., Oct. 18, 2011 For thousands of nurses, lab ... challenge of shopping for the latest in scrub fashions that ... Building on the success of the 10 original stores that ... set to open in Tampa, Orlando and Miami FL; Rochester ...
... BALTIMORE, Oct. 18, 2011 Ohio-based AdCare Health ... has selected Remedi SeniorCare®, one of the nation,s ... and consulting services for AdCare,s facilities  that deliver ... Ohio region. Remedi pharmacy services will ...
Cached Medicine Technology:An RX for Busy Healthcare Professionals 2An RX for Busy Healthcare Professionals 3AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions 2AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions 3
(Date:8/30/2014)... (PRWEB) August 30, 2014 The Plastic ... in New Jersey and even in the U.S. to ... takes inches off of patients’ waists with deep-tissue heating. ... in small sections, Vanquish is more inclusive to target ... Patients lay comfortably under panels about one inch away ...
(Date:8/30/2014)... NY (PRWEB) August 30, 2014 ... U.S. Open Tennis Championship tickets in NYC. ... appreciation promo/coupon code US-OPEN-2014 for all day session, evening ... and group sales for this prestigious Grand Slam Tournament. ... below: , 8/30/14 , US Open Tennis Championship: Men's/Women's ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Acne is a common ... cases acne is nothing more than a daily nuisance, for some, ... Severe cases of acne can even lead to dramatic mood swings ... to try anything to clear up their skin. In some cases, ... and money through trial and error, those on a quest for ...
(Date:8/30/2014)... 2014 Hundreds of Byetta lawsuits ( ... move forward in U.S. courts, Bernstein Liebhard LLP reports. ... July 31, 2014, Byetta and Bydureon (an extended-release version ... claims that allege the drugs caused pancreatitis, pancreatic cancer ... these claims are pending in a multidistrict litigation underway ...
(Date:8/30/2014)... Randy Dotinga HealthDay ... About one in five patients operated on for broken bones ... surgery, a new study finds. Less-educated patients and ... more likely to be "doctor shoppers," said study lead author ... Ky. Overall, he said, the study suggests that doctors aren,t ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, The Plastic Surgery Group 2Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 2Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 3Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 4Health News:US Open Tennis Tickets: Ticket Down Slashes Ticket Prices for Labor Day Weekend Sessions and More 5Health News:Acne Treatment Reviews Added to Popular Treatment Website 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3
... Payors To,Become Engaged and Accountable, WASHINGTON, Sept. 9 ... Medco Health Solutions, Inc. (NYSE: MHS ) Chairman,and ... for fixing,America,s inefficient health care system that, for the ... the problem. Unifying the strengths,of both the public and ...
... not in a state of craving, they may underestimate intensity ... (HealthDay News) -- If you,re not craving a hit of ... battle just got a little tougher, say researchers at the ... have observed previously that the idea of smoking a cigarette ...
... Transcend Medical, Inc., an,ophthalmic device company dedicated to delivering ... J. Walsh was named as President,and Chief Executive Officer ... Chairman of the Board of Directors., "Brian is ... de Juan,Jr., M.D., the founder of ForSight Labs, the ...
... Delta Dental funding pioneer studies to improve oral health for youngsters ... ... Mich., Sept. 9 The affiliated companies of,Delta Dental of Michigan, ... if sugarless lollipops containing,licorice extract can reduce the bacteria that causes ...
... Award To Johns Hopkins University Scientists, LISBON, Portugal ... of the largest global science foundations, today announced,the recipients ... ($1.4 million),Antonio Champalimaud Vision Award, referred to as the ... A.P.J. Kalam, is the largest,monetary prize in the field ...
... stop on AHIP,s listening tour; Reducing health disparities ... America,s Health,Insurance Plans, (AHIP) Campaign for an American ... which local government, business,health care and community leaders ... disparities in care experienced by diverse communities., ...
Cached Medicine News:Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 3Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 4Health News:Study Probes Why Smokers Find It Hard to Quit 2Health News:Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board 2Health News:Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board 3Health News:How Many Licks Does it Take to Reduce Tooth Decay? 2Health News:How Many Licks Does it Take to Reduce Tooth Decay? 3Health News:How Many Licks Does it Take to Reduce Tooth Decay? 4Health News:Two U.S. Researchers Win Prestigious International Science Award 2Health News:Two U.S. Researchers Win Prestigious International Science Award 3Health News:Health Insurance Industry Hosts Roundtable Discussion on Health Care Reform in Albuquerque 2Health News:Health Insurance Industry Hosts Roundtable Discussion on Health Care Reform in Albuquerque 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: